While this is plenty interesting, what's also worth pointing out that this is yet another example of an existing drug being shown to have anti-cancer activity. Crafting new drugs from scratch takes years and many millions of dollars, re-using existing drugs is much cheaper as a lot of the trials of toxicity and pharmacology have already been done. The combination of off-label drugs is an area that we are keen to see exapnd. Few of these drugs have direct cancer killing activity, but what they do is act gently to change the environment around the tumours. By attacking the tumour microenvironment you subvert the mechanisms that the tumour puts in place to survive.
A list of some of the most promising off-label drugs with anti-cancer activity include:
- Metformin - targets tumour metabolism, (read up on the reverse warburg effect, for example)
- Statins - targets the mevalonate pathway (starves the tumour of esential building blocks for cell proliferation)
- Aspirin - targets the inflammatory environment
- Beta-blockers - targets the beta-adrenergic pathway
- Naltrexone and methylnatrexone - target the mu-opiod receptor pathway